INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $210,547 | -11.5% | 5,163 | +21.5% | 0.00% | -40.0% |
| Q3 2022 | $238,000 | +13.9% | 4,250 | +5.2% | 0.01% | +25.0% |
| Q2 2022 | $209,000 | -12.9% | 4,040 | +22.1% | 0.00% | 0.0% |
| Q1 2022 | $240,000 | -38.3% | 3,308 | +0.4% | 0.00% | -33.3% |
| Q4 2021 | $389,000 | -10.8% | 3,294 | +1.4% | 0.01% | -25.0% |
| Q3 2021 | $436,000 | -23.0% | 3,247 | -7.2% | 0.01% | -20.0% |
| Q2 2021 | $566,000 | – | 3,498 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 1,859,926 | $301,141,000 | 48.58% |
| Burrage Capital Management LLC | 63,634 | $10,303,000 | 10.33% |
| Elmwood Wealth Management, Inc. | 67,174 | $10,876,000 | 5.73% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 300,327 | $48,626,000 | 4.72% |
| Discovery Value Fund | 929,669 | $150,523,000 | 4.08% |
| Ikarian Capital, LLC | 294,400 | $47,667,000 | 3.85% |
| Ally Bridge Group (NY) LLC | 93,127 | $15,078,000 | 3.75% |
| GREAT POINT PARTNERS LLC | 100,000 | $16,191,000 | 3.40% |
| ARK Investment Management | 7,684,441 | $1,244,188,000 | 2.32% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $18,043,000 | 2.30% |